These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32300857)

  • 1. Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential.
    Bewarder M; Held G; Thurner L; Stilgenbauer S; Smola S; Preuss KD; Carbon G; Bette B; Christofyllakis K; Bittenbring JT; Felbel A; Hasse A; Murawski N; Kaddu-Mulindwa D; Neumann F
    Cancer Immunol Immunother; 2020 Aug; 69(8):1535-1548. PubMed ID: 32300857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Releasing the concept of HLA-allele specific peptide anchors in viral infections: A non-canonical naturally presented human cytomegalovirus-derived HLA-A*24:02 restricted peptide drives exquisite immunogenicity.
    Pump WC; Schulz R; Huyton T; Kunze-Schumacher H; Martens J; Hò GT; Blasczyk R; Bade-Doeding C
    HLA; 2019 Jul; 94(1):25-38. PubMed ID: 30912293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
    Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
    J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
    Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
    Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
    J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
    Lim JB; Kim HO; Jeong SH; Ha JE; Jang S; Lee SG; Lee K; Stroncek D
    J Transl Med; 2009 Aug; 7():72. PubMed ID: 19698161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life.
    Attaf M; Roider J; Malik A; Rius Rafael C; Dolton G; Predergast AJ; Leslie A; Ndung'u T; Kløverpris HN; Sewell AK; Goulder PJ
    Front Immunol; 2020; 11():1587. PubMed ID: 33101265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
    Cho HI; Han H; Kim CC; Kim TG
    J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.
    Borysiewicz LK; Morris S; Page JD; Sissons JG
    Eur J Immunol; 1983 Oct; 13(10):804-9. PubMed ID: 6196203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection.
    Abels WC; Manandhar T; Kunze-Schumacher H; Blasczyk R; Bade-Döding C
    Immunogenetics; 2018 Nov; 70(10):639-646. PubMed ID: 30128813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection.
    Diamond DJ; York J; Sun JY; Wright CL; Forman SJ
    Blood; 1997 Sep; 90(5):1751-67. PubMed ID: 9292508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine.
    Zhao P; Ma DX; Yu S; Xue FZ; Zhu WW; Shao N; Zhang JR; Ji CY
    Antiviral Res; 2012 Feb; 93(2):260-269. PubMed ID: 22197248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules.
    D'Orsogna LJ; van den Heuvel H; van der Meer-Prins EM; Roelen DL; Doxiadis II; Claas FH
    J Immunol; 2012 Nov; 189(10):4825-31. PubMed ID: 23077240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection.
    Wynn KK; Fulton Z; Cooper L; Silins SL; Gras S; Archbold JK; Tynan FE; Miles JJ; McCluskey J; Burrows SR; Rossjohn J; Khanna R
    Blood; 2008 Apr; 111(8):4283-92. PubMed ID: 18270323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.